Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System Savara Inc. (Nasdaq: SVRA) (the Company), a clinical ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) ...
ORLANDO, Fla.--(BUSINESS WIRE)--AireHealth, an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking and early detection of ...
Mesh nebulizers have more frequent drug side effects and may cause a higher increase in heart rate than compressor nebulizers in pediatric patients with asthma. Pediatric patients with asthma using ...
Introduction: Platelet lysate (PL) demonstrates antimicrobial and anti-inflammatory properties offering potential for treatment of bacterial pneumonia in horses. It remains unknown whether ...
An ordinary home network router with a Wi-Fi 5 or Wi-Fi 6 access point is usually enough for most homes with a modest living space and central internet serving phones, laptops, and other everyday ...
Sarfraz is an avid PC enthusiast who has a decade of experience in PC hardware. He has written extensively on all types of consumer PC components and peripherals on Xtremegaminerd since the time when ...
Abstract: We present results from a vibrating mesh nebulizer for which the mesh is a micro-machined silicon membrane perforated with up to a thousand micron-sized, pyramidal holes. Finite element ...
The RespiRx. [Image courtesy of Qnovia] Qnovia announced positive results from its first-in-human study for the QN-01 inhaled smoking cessation therapy. Richmond, Virginia-based Qnovia develops the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback